Long Term CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin Injections

Exclusion Criteria

• •Pregnancy, planned pregnancy for the study duration or pregnancy during the last six months
• •Severe cognitive dysfunction or other disease, which is adjudicated by a physician as not suitable for inclusion.
• •Required continuous use of paracetamol. Paracetamol must not have been used the week before the study and shall not be used during CGM-use because it disturbs the interpretation of blood glucose levels estimated by the Dexcom. However, other pain killers can be used throughout the study duration.
• •History of allergic reaction to any of the CGM materials or adhesives in contact with the skin, or to chlorhexidine or alcoholic anti-septic solution.
• •Abnormal skin at the anticipated glucose sensor attachment sites (excessive hair, burn, inflammation, infection, rash, and/or tattoo).
• •Other investigator-determined criteria making patients unsuitable for participation.